Delivery Order SPE2DB20D1100-SPE2DB24FD2X9
Award Date
8/15/24
Potential Completion Date
9/6/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the provision of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract has a completion date of February 27, 2025 and is a firm fixed-price delivery order contract. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a ceiling value of $12,346.74 and a performance period ending on February 11, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a ceiling value of $11,934.27. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of September 13, 2024. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, and has a ceiling value of $4,115.58. The contract is a firm fixed-price arrangement with a completion date of February 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price ceiling value of $11,934.27 and an ultimate completion date of August 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564594203 - TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract does not have a set-aside designation and is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of May 31, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,978.08, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. No...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of TESTOPEL 75 MG PELLETS. The $3,978.09 contract has a completion date of March 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and a for-profit organization. This award is issued under an indefinite delivery contract (IDC) with DLA, with a potential value of $999,999,999.00 and a performance period...